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A B S T R A C T
Breast cancer rates are lower amongst women from more socio-economically deprived areas. However, their
mortality rates are higher. One explanation of this breast cancer paradox is that women from more deprived
areas are less likely to attend breast cancer screening programmes. This systematic review is the first to examine
this issue in Europe. A systematic review of Embase, Medline and PsychINFO (from 2008 to 2019) was un-
dertaken (PROSPERO registration number: CRD42018083703). Observational studies were included if they were
based in Europe, measured breast cancer screening uptake, compared at least two areas, included an area-level
measure of socio-economic deprivation and were published in the English language. The Joanna Briggs Institute
critical appraisal checklist was used to assess study quality and risk of bias. Thirteen studies from seven different
European countries met our inclusion criteria and were included in the review. In ten of the thirteen studies,
there was a significant negative association between screening uptake and area-level socio-economic deprivation
– with women living in more socio-economically deprived neighbourhoods less likely to attend breast cancer
screening. Although universal screening programmes were provided in most studies, there were still strong
negative associations between screening uptake and area-level socio-economic deprivation. Future breast cancer
screening strategies should acknowledge these challenges, and consider developing targeted interventions in
more deprived areas to increase screening participation.
1. Introduction
Breast cancer is the most common type of cancer in women, ac-
counting for 28% of total cancer cases across Europe [1]. In 2014,
92,500 women died from breast cancer in the EU-28 [2]. Through
better diagnostic techniques and advancement in surgical and phar-
macological treatment, mortality rates from breast cancer are de-
creasing [1]. However, there are substantial socio-economic inequal-
ities in breast cancer prevalence and mortality: women in more socio-
economically deprived areas have lower breast cancer incidence, but
higher mortality rates [3]. For example, in England, incidence rates for
breast cancer are 14% lower for women living in the most deprived
areas, compared to the least deprived, while people living in the most
deprived areas have a significantly higher mortality rate – with an es-
timated 350 yearly excess deaths [4]. This breast cancer paradox may
be attributable to later diagnosis [5], suboptimal cancer care [6], co-
morbidities that may limit treatment options or increase the possibility
of developing treatment complications [7], and – most notably in terms
of prevention – lower rates of breast cancer screening uptake.
In Europe, most countries have implemented or are developing
mammography-based universal breast cancer screening programmes. It
has been widely acknowledged that breast cancer screening is not
without disadvantages, including breast cancer over diagnosis, which
can lead to unnecessary surgical and pharmacological intervention. In
view of this, many experts believe that the risks of breast cancer
screening can outweigh the benefits, and women should always be fully
informed about the risks and benefits of screening. Despite these lim-
itations, the literature has shown that breast cancer screening can po-
sitively impact on survival [8]. However, even with universal screening
programmes available in many European countries, there are still dis-
tinct area-based inequalities in breast cancer screening uptake related
to socio-economic deprivation [9–13].
A systematic review by Pruitt et al. [14] examined the association
between socio-economic deprivation and breast, cervical and colorectal
cancer screening. The work included 13 studies for breast cancer
screening – all of which were conducted in North America, and showed
some positive associations between socio-economic status (SES) and
screening uptake [14], indicating that as SES increased (i.e. increasing
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income and education, decreasing unemployment and poverty), the
odds of attending cancer screening increased. However, no European
studies were included in this systematic review and given the sub-
stantial differences in healthcare systems and screening coverage be-
tween the USA and Europe, it is important to examine if there is also an
association in universal European health systems. Our systematic re-
view, therefore, aimed to examine the association between area-level
socio-economic deprivation and breast cancer screening uptake in
Europe.
2. Materials and methods
2.1. Study design and inclusion criteria
The systematic review is registered with PROSPERO
(CRD42018083703) and is reported according to the Preferred
Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA)
guidelines [15] (Appendix A). We included observational studies (cross-
sectional; prospective and retrospective cohorts, time series, repeat
cross-sectional) of adult women (> 18 years) in high-income European
countries (defined as European countries in the Organisation of Eco-
nomic Cooperation and Development). To be included in the review,
studies had to compare at least two areas and have some area-level
measure of socio-economic deprivation. Area-level socio-economic de-
privation can be measured differently, but essentially involves ranking
areas on the basis of relative local scores for factors such as income,
employment and housing quality. Common measures include indices of
multiple deprivation, percentage of poverty, or percentage un-
employed. The primary outcome of interest was breast cancer screening
participation. This included attending mammography, clinical breast
examination (CBE), and ultrasound, but excluded self-breast examina-
tion. The screening could have been as either part of a screening pro-
gramme, through referral by a healthcare professional, through health
insurance or by any other certified method. In keeping with the pre-
vious systematic review by Pruitt et al. [14], studies had to be published
in English and in peer-reviewed journals (to enhance quality); any
studies only published as abstracts were excluded.
2.2. Search strategy
Our search terms are detailed in Table 1. The search strategy was
adapted from Cairns et al. [16] who investigated the association of
area-level socio-economic deprivation and suicidal behaviour, with
additional breast cancer and screening terms. A pilot search was un-
dertaken to identify three indicator papers [17–19]. Three electronic
databases were searched between 1 st January 2008 and 28th January
2019 (host sites given in parentheses): Medline (via OVID), Embase (via
OVID) and PsycINFO (via OVID). The search start date of 2008 was
chosen because our review updates the systematic review by Pruitt
et al. [14]. Citation follow up of all included articles was also con-
ducted.
2.3. Data extraction and quality appraisal
Screening, data extraction and quality appraisal were conducted by
two reviewers (DS and KT). Study inclusion agreement between the
reviewers was 95% with a kappa score of fair (κ=0.48) [20], as the
first reviewer was more inclusive (all full texts were identified by both
reviewers). The methods and main study findings of each study were
extracted using a bespoke data extraction form. Data extraction and
quality appraisal were conducted by DS and checked in full by KT; any
discrepancies were resolved through discussion between the reviewers
and then if agreement could not be reached by consensus through
consulting the project lead (AT). Quality appraisal was conducted using
the checklist for analytical cross sectional studies produced by the
Joanna Briggs Institute (JBI) [21]. The checklist includes questions
relating to sampling, inclusion criteria, confounding, types of outcomes
and statistical analyses (Appendix B). Arbitrary labels of low (1–4),
moderate (5 and 6) and high (7 and 8) were assigned to each primary
study for ease of reporting.
2.4. Analysis and synthesis
A narrative synthesis thematically describing studies by country was
undertaken. Studies used heterogeneous measures so meta-analysis was
not possible. We report on the overall association between area-level
deprivation and breast cancer screening uptake in terms of (1) the gap
(between the best and the worst off areas); and (2) the gradient (across
the whole spectrum of deprivation) [22].
3. Results
A total of 2125 unique citations were retrieved from the searches.
Reasons for exclusion at the full paper stage (n= 77) are detailed in
Fig. 1 (with further details in Appendix C). In total, 13 unique primary
studies (representing 14 articles) from seven countries were included in
the review: England (n=4, from 5 articles) [23–27], France (n=3)
[19,28,29], Germany (n= 1) [30], Italy (n=1) [31], Sweden (n=1)
[18], the Netherlands (n=1) [17] and Turkey (n= 2) [32,33]. All
countries ran screening programmes, although it is acknowledged that,
in Turkey, breast cancer screening is still performed primarily on an
opportunistic basis [32,33]. The included studies examined screening
Table 1
Search terms.
[(breast cancer AND mammo*) OR (breast cancer AND screen*) OR (mammo*) AND
(socioeconomic OR SES OR education* OR employment OR income OR
occupation* OR poverty OR class OR depriv* OR disadvantage* OR social class
OR social factors OR economic OR unemployment) AND (area* OR geo* OR
place OR neighbourhood OR neighbhorhood OR region* OR county OR ward OR
city OR district OR county OR census tract OR metropolitan OR zip code)] Fig. 1. Prisma flow chart showing study selection.
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Table 2
Summary table of included studies.
Study and source
of funding
Design Year(s) Scale Screening
interval
Outcomes(s) Measure of
deprivation
Results
(Confidence
intervals given
in square
brackets)
Methodological
quality
Deprivation effect
Gap (+/-) Gradient
(✓/ x)
England
Massat et al.
[26]
Funding: UK
Department of
Health
Cross-
sectional
April
2011 –
March
2012
District
Unit of
analysis:
Primary
Care Trusts
3 years % of eligible women
who had adequate
mammography in
the last 3 years
Percentage
deprivation using
the Index of
Multiple
Deprivation
(IMD) 2010
Model:
Population and
general practice-
level variables
OR 0.991
[0.985, 0.997]
8/8 (high) ✓ – * NR
Renshaw et al.
[27]
Funding: Not
listed
Cross-
sectional
April
2004 –
March
2007
Neighbourh-
ood
Unit of
analysis:
LSOA
3 years Attendance at breast
screening
Income quintile
of the IMD 2004
% Sceening
attendance
given in
brackets
1. (least
deprived): OR
1.00 (69.2%)
2. OR 0.92
[0.91, 0.94]
(67.5%)
3. OR 0.82
[0.81, 0.84]
(64.9%)
4. OR 0.70
[0.69, 0.71]
(61.1%)
5. OR 0.52
[0.51, 0.53]
(53.8%)
6/8 (medium) ✓ – * ✓ – *
Jack et al.
[24,25]
Funding: The
London
Quality
Assurance
Centre and the
Thames
Cancer
Registry
Cross-
sectional
March
2006 –
Decemb-
er 2009
Neighbourh-
ood
Unit of
analysis:
LSOA
3 years Women’s earliest
invitation to
screening was
examined (split
between first call
invitation [for those
women aged 50-52]
and women aged 50-
69 who had a
routine recall
invitation)
Income domain
of the IMD 2007
2014 article:
First call (%
attended):
1 (most
affluent): 66%
2 67%
3 63%
4 60%
5 56%
Routine recall
(% attended):
1 (most
affluent): 79%
2 79%
3 77%
4 74%
5 70%
2016 article:
OR 0.95
p<0.001
6/8 (medium) [25]:
First call:
✓ – NR
Routine
recall:
✓ – NR
[24]:
✓ – *
[25]:
First call:
x
Routine
recall:
✓ NR
[24]:
x
Douglas et al.
[23]
Funding: UK
Department of
Health
Cross-
sectional
2007-
2012
District
Unit of
analysis:
Primary
Care Trusts
3 years % of eligible women
who had adequate
mammography in
the last 3 years
IMD (2010)
aggregated to
PCT level
2007-2008
(average
percentage
coverage in
brackets):
1 (least
deprived): RR
1.00 (79%)
2. RR 0.99
[0.98, 1.00]
(77%)
3. RR 0.94
[0.93, 0.95]
(73%)
4. RR 0.94
[0.93, 0.95]
(74%)
5. RR 0.85
[0.84, 0.86]
(66%)
2012-13:
1 (least
deprived): RR
1.00 (78%)
6/8 (medium) 2007-8:
✓ – *
2012-13:
✓ – *
2007-8:
x
2012-13:
x
(continued on next page)
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Table 2 (continued)
Study and source
of funding
Design Year(s) Scale Screening
interval
Outcomes(s) Measure of
deprivation
Results
(Confidence
intervals given
in square
brackets)
Methodological
quality
Deprivation effect
Gap (+/-) Gradient
(✓/ x)
2. RR 1.00
[0.99, 1.01]
(78%)
3. RR 0.96
[0.95, 0.97]
(75%)
4. RR 0.95
[0.94, 0.96]
(74%)
5. RR 0.89
[0.88, 0.90]
(70%)
France
Pornet et al.
[29]
Funding: Not
reported
Cross-
sectional
2004 –
2006
Neighbourh-
ood
Unit of
analysis:
IRIS
2 years Screening
mammography
within the duration
of the study
The Townsend
Index
Model: 2
1 (least
deprived): OR
1.00 (60.29%)
2. OR 0.94
[0.74, 1.20]
(59.18%)
3. OR 0.90
[0.70, 1.14]
(58.10%)
4. OR 0.82
[0.66, 1.02]
(56.04%)
5. OR 0.71
[0.59, 0.86]
(52.11%)
8/8 (high) ✓ – * ✓ NS
Ouedraogo et
al. [19]
Funding: ‘La
Ligue Contre le
Cancer’ and ‘la
‘Fondation de
France’
Cross-
sectional
2010 –
2011
Neighbourh-
ood
Unit of
analysis:
IRIS
Not
reported
Attended invitation
to mammography
screening between
2010 and 2011
The French
European
Deprivation
Index
Model: Multilevel
logistic regression
analyses
% Screening
given in
brackets
1 (least
deprived): OR
1.00 (43.9%)
2. OR 0.94
[0.87, 1.02]
(30.6%)
3. OR 0.84
[0.78, 0.92]
(25.4%)
8/8 (high) ✓ – * ✓ NS
Deborde et al.
[28]
Funding: Not
reported
Cross-
sectional
2013-
2014
District
Unit of
analysis:
Municipality
2 years Age-standardised
participation rate
The French
Deprivation
Index
% Attending
screening:
1 (least
deprived):
44.9%
2 54.2%
3 53.8%
4 54.8%
5 52.1%
6/8 (medium) ✓ + NR x
Germany
Lemke et al.
[30]
Funding: Not
reported
Cross-
sectional
2007 -
2008,
2009 -
2010,
2011-
2012
Neighbourh-
ood
Unit of
analysis:
Not
specified
2 years Participation in
screening for each
two year period
Unemployment
rate (foreigner %)
Model:
Multivariable
analysis
Unemployment
rate (foreigner)
OR 0.94 [0.90,
0.98]
7/8 (high) ✓ – * NR
Italy
Giuliani et al.
[34]
Funding: San
Paolo
Foundation
Cross-
sectional
1990 –
2000
(the
time
period
patients
were
diag-
nosed
Neighbourh-
ood
Unit of
analysis:
Level of
census
section
Screening
for breast
cancer
survivors
Yearly mammogram
and CBE
Deprivation index Affluent
(reference)
class: OR 1.00
Deprived class:
OR 0.81 [0.65,
1.00]
8/8 (high) ✓ – NS NR
(continued on next page)
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uptake over different time intervals – the shortest of which was in
Sweden [18] (1.5–2 years), while the longest screening interval was in
England (3 years) [23–27]. The majority of the studies used small
neighbourhood areas containing approximately 1500 residents called
Lower Super Output Areas [25,27]; IRIS - French ‘aggregated units for
statistical information’ [19,29]; or SAMS - Small Areas for Market
Statistics [18]), although some used larger districts containing several
hundred thousand residents (e.g. using English Primary Care Trust
geographies [23,26]). Study size varied greatly: the largest comprised
4,805,390 women in all departments in mainland France [28], whilst
the smallest was a single French department in the Normandy region of
north-western France [29], involving 4940 women. Twelve of the
thirteen studies examined mammography attendance
[17–19,23–30,32,33], whilst the other reported mammography and
clinical breast examination attendance [34]. A variety of methods were
employed in the primary studies to measure deprivation: most of the
papers used composite measures of deprivation; for example the Index
of Multiple Deprivation [23–27], the French European Deprivation
Index [19,28], the Townsend Index [29,35], or other composite indices
[17,18,34]; the other studies used single indicators [30,32,33]. The
methodological quality of nearly half (6/13) of the included studies was
high – with scores ranging from 2/8 (low) to 8/8 (high) (Appendix D).
Table 2 (continued)
Study and source
of funding
Design Year(s) Scale Screening
interval
Outcomes(s) Measure of
deprivation
Results
(Confidence
intervals given
in square
brackets)
Methodological
quality
Deprivation effect
Gap (+/-) Gradient
(✓/ x)
with
breast
cancer),
followed
up until
2010
The Netherlands
Aarts et al.
[17]
Funding:
Bevolkings
Onderzoek
Borstkanker
Zuid
Cross-
sectional
1998 –
2005
Neighbourh-
ood
Unit of
analysis:
Postcode
2 years Screening
mammography
attendance
Indicator of SES
(based on house
value and
income)
Low SES: OR
1.00 (79%)
Intermediate:
OR 1.54 [1.5,
1.6] (85%)
High: OR 1.75
[1.7, 1.8] (87%)
6/8 (medium) ✓ – * ✓ *
Sweden
Lagerlund et
al. [18]
Funding: Not
reported
Cross-
sectional
2005 –
2009
Neighbourh-
ood
Unit of
analysis:
SAMs
1.5-2 years Non-attendance to
most recent
mammography
screening during
2005 to 2009
Neighbourhood
sociodemo-
graphic index
Model: 3
Lowest %
neighbourhood
sociodemo-
graphic index
(decile group 1:
least deprived):
OR 1.00
Decile group 5:
OR 1.26 [1.07,
1.51]
Highest %
neighbourhood
sociodemo-
graphic index
(decile group
10): OR 1.92
[1.63, 2.34]
8/8 (high) ✓ – * ✓ *
Turkey
Dundar et al.
[32]
Funding:
None
Cross-
sectional
2008 –
2009
Regions
Unit of
analysis:
Regions of
Mansia
2 years Attended screening
between 2008 –
2009
Education,
perceived family
income
Attendees %
Urban (70.5%),
slum (81.6%)
2/8 (low) ✓ + * NR
Ozmen et al.
[33]
Funding: Not
listed
Cross-
sectional
Dates
not
stated
City
Unit of
analysis:
City (Mus)
and county
(Bahcesehir)
in Istanbul
Opportuni-
stic
screening
Screening
mammography in
the last two years
Literacy,
graduation,
working status,
monthly income
Attendees %
Mus – more
deprived (35%)
Bahcesehir
(49%)
2/8 (low) ✓ – * NR
OR indicates odds ratio.
RR indicates relative risk.
- indicates a negative association between area-level deprivation and breast cancer screening (i.e. the higher area-level deprivation, the lower the uptake of breast
cancer screening).
- indicates a positive association between area-level deprivation and breast cancer screening (i.e. the higher area-level deprivation, the higher the uptake of breast
cancer screening).
NR indicates data not reported in study.
*Significance at p<0.05.
NS indicates gap/gradient not significant.
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3.1. Overall findings
Regardless of indicator of area-level socio-economic deprivation,
11/13 studies (of which 10 were statistically significant) demonstrated
a negative association between area-level deprivation and screening –
with women living in more socio-economically deprived neighbour-
hoods less likely to attend breast cancer screening. Eight studies also
examined the gradient (comparing more than two areas), and six de-
monstrated a socio-spatial gradient (three of which were statistically
significant). The results for each study are narratively synthesised by
country. Table 2 gives an overview of study characteristics and main
findings, while Fig. 2 summarises the results of the studies that included
odds ratios for breast cancer screening uptake.
3.2. Country specific findings
3.2.1. England (n=4)
Four studies (from five articles) examined the association between
area-level deprivation and uptake of the English Breast Screening
Programme (one high methodological quality, three medium). All four
studies [23–27] found a negative association between screening uptake
and area-level deprivation. The papers by Jack et al. [24,25] observed
both a gap and a gradient for the proportion of women who attended a
first call for screening (significance not reported). The work by Massat
et al. [26] found a statistically significant deprivation gap in uptake.
Renshaw et al. [27] showed a gradient, whereby screening attendance
was highest amongst the most affluent and fell significantly as depri-
vation levels increased. Douglas et al. [23] observed screening rates
over a five year period and demonstrated a gap in all years and a
gradient in all but one of the years. These findings suggest that there is a
reduction in area-based screening inequalities from the years
2007–2008 to 2012-2013.
3.2.2. France (n= 3)
Two of the three French studies (considered to have high metho-
dological quality), found a negative association between deprivation
and screening uptake. Ouedraogo et al. [19] and Pornet et al. [29]
found a significant gap where women living in the most deprived
neighbourhoods were significantly less likely than those living in the
most affluent to participate in breast cancer screening. They also noted
a gradient, but these were not statistically significant in either study.
The study by Deborde et al. [28], using a larger unit of analysis (mu-
nicipalities), found an inverted U-curve relationship between depriva-
tion and screening participation, with highest screening found in the
intermediate quintiles.
3.2.3. Germany (n=1)
The one high-quality study by Lemke et al. [30] found that in areas
with a higher employment rate, women were more likely to attend
breast cancer screening. However, this association was only statistically
significant for foreigner unemployment rate, and not for other types of
unemployment.
3.2.4. Italy (n= 1)
A high-quality study by Giuliani et al. [34] only included partici-
pants who had been diagnosed with either in situ or invasive breast
cancer and received surgical intervention. The results showed that
those in the deprived group were less likely to attend yearly mammo-
graphy screening and/or clinical breast examination compared to those
in the reference group (but this gap was not statistically significant).
3.2.5. Netherlands (n= 1)
Aarts et al. [17] explored breast cancer screening uptake in southern
Netherlands by tertiles of deprivation. This medium-quality study found
a statistically significant gap and gradient in breast cancer screening
uptake.
3.2.6. Sweden (n= 1)
Lagerlund et al. [18] explored non-attendance at mammography
screening and neighbourhood sociodemographic characteristics in
southwest Sweden. Both a gap and gradient effect was observed (sig-
nificance not given) in this high-quality study: decreasing deprivation
was associated with an increase in the proportion of women who attend
screening appointments.
3.2.7. Turkey (n= 2)
Two studies conducted in Turkey were identified, both of which
were rated as low in quality. Dundar et al. [32] found that women in a
more affluent, urban district were significantly less likely to attend the
breast cancer screening programmes compared with those in the de-
prived district. Another study, by Ozmen et al. [33], compared the
mammography screening behaviours of women in two socio-econom-
ically contrasting cities – with those in the more affluent city sig-
nificantly more likely to have had a mammogram within the last two
years.
4. Discussion
This review has found consistent, medium-high quality evidence of
a negative association between area-level socio-economic deprivation
and breast cancer screening uptake in Europe (i.e. as area level socio-
economic deprivation increases, breast cancer screening uptake
Fig. 2. The association between area level socio-economic deprivation and breast cancer screening uptake for studies reporting odds ratios.
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decreases). This work updates a previous systematic review exploring
the association between breast cancer, colorectal cancer, and cervical
cancer screening and area-level deprivation [14]. In this systematic
review, which only included studies from outside Europe, thirteen
studies focused on breast cancer screening; eight of which showed
significant positive associations between SES and screening uptake. Our
work, which focused on studies in Europe, supports the findings of the
previous review by Pruitt et al. and provides evidence that even in the
more universal health systems of Europe, women living in the least
deprived areas are more likely to attend breast cancer screening than
women living in the most deprived areas. Our work also builds on
previous findings that as individual level SES increases, the uptake of
breast cancer screening also increases [36,37], although the relation-
ship between individual and area-level factors are thought to be com-
plex with one not being a simple proxy for the other in terms of breast
cancer risk [38]. Qualitative research provides contextual information
to understand the reasons for low rates of screening in deprived areas.
Evidence suggests that women living in areas of high deprivation had
limited knowledge about mammography screening programmes or had
misconceptions regarding cancer and mammography [12,39]. Embar-
rassment, fear and inconvenience have also been cited as possible
reasons for low screening rates in these communities [40]. Further-
more, passive and practical barriers have been highlighted by an Aus-
tralian Government Report [41] suggesting women in deprived com-
munities find it difficult to attend mammography, because of transport
(cost, availability) or family commitments.
It is possible that the reduced screening uptake in deprived areas
contributes to the ‘breast cancer paradox’, whereby rates of breast
cancer survival are reduced in deprived communities, despite there
being lower disease incidence. Although there is debate about the role
of breast cancer screening, screening does allow for early disease de-
tection, which can result in earlier treatment initiation and better
outcomes for patients. By not attending routine breast cancer screening,
it is possible that the disease would be discovered at a more advanced
stage, potentially resulting in poorer outcomes for patients. Although
we acknowledge that reduced screening uptake in deprived commu-
nities is not solely responsible for the higher breast cancer mortality
rate. With respect to disease incidence, high SES enhances certain be-
haviours that reduce breast cancer incidence, including reduced levels
of smoking, lower alcohol consumption and increased physical activity.
There are, however, other factors that increase breast cancer incidence
in women of high SES, such as increased nulliparity, having children at
an older age, and the use of the combined oral contraceptive pill
[42–45]. It is thought that these latter factors contribute to the in-
creased incidence of breast cancer in women of higher SES.
Our findings are in line with the fundamental cause theory [46],
whereby people with greater access to resources, including knowledge,
money, power, prestige, and beneficial social connections are better
able to take advantage of effective innovations in disease prevention
and treatment. The theory predicts that, in people of higher SES,
whenever technology and medical knowledge are available to manage a
particular disease, the mortality rates of that disease will be lower. It is
imperative then, that national breast cancer screening strategies across
Europe and elsewhere, recognise the negative association of breast
cancer screening uptake with area-level deprivation, and, potentially,
how this could affect breast cancer mortality. Increasing knowledge, by
targeting women of low socio-economic status and informing them of
the benefits (and risks) of breast cancer screening and also providing
practical steps to ensure mammography screening is fully accessible in
deprived areas (e.g. by the use of mobile clinics) are thus potential
routes to increase uptake. Small scale studies have demonstrated it is
possible to achieve this; for example, Chambers et al. showed that a
brief telephone support intervention doubled breast cancer screening
attendance in women from deprived areas in Scotland who had missed
their initial screening appointment [47]. Another study, undertaken by
Kerrison et al. [48], showed that a text message reminder increased the
uptake of routine breast cancer screening appointments for people
living in the London Borough of Hillingdon. The findings of also sug-
gested that text message reminders are particularly effective for in-
creasing screening attendance among patients from deprived areas.
Moving forward, it is important for these interventions to be tested at a
national level and, if successful, be implemented into breast cancer
screening policy.
This review is subject to some limitations. Firstly, we only included
studies from European countries – we did not include studies from other
high-income countries, such as the USA and Canada, nor did we analyse
our findings according to healthcare system type [49,50]. Our findings,
therefore, may not be generalisable to all types of healthcare systems.
Secondly, this review is subject to the usual limitations of observational
research whereby we cannot claim that there is a causal relationship
between area-level disadvantage and breast cancer screening uptake. It
is not clear how this association impacts on overall breast cancer sur-
vival, if at all – this limitation is even more pertinent in view of the
debate around the risks and benefits of breast cancer screening [51].
Thirdly, other limitations due to practical resources include not being
able to search for grey literature and unpublished studies. The studies
included were also limited to the English language. Finally, as an evi-
dence base we have only found a limited number of studies, and
therefore it is possible that there is publication bias (that negative re-
sults are less likely to be published) and selective reporting within
studies which may impact the assessment of risk of bias.
5. Conclusion
The findings from this review provide evidence that there is lower
uptake of breast cancer screening in areas experiencing higher levels of
socio-economic deprivation in Europe. Strategies to improve breast
cancer screening attendance should be aimed at more deprived areas, to
increase individual participation and decrease inequalities in the gen-
eral population. Further research should explore how the reduced
breast cancer screening uptake in areas of high socio-economic depri-
vation impacts on breast cancer survival and the breast cancer paradox.
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